Alfacalcidol is a synthetic vitamin D3 analogue, also known as 1α-hydroxycholecalciferol or 1α-hydroxyvitamin D3. It is a vitamin D derivative involved in calcium and phosphate regulation and bone metabolism.
Alfacalcidol is converted in the liver to 1,25-dihydroxyvitamin D, the biologically active form of vitamin D. It is used in pharmaceutical formulations for conditions associated with impaired vitamin D metabolism and disturbances in calcium and bone metabolism, including certain cases of renal bone disease.
Alfacalcidol is used as an active pharmaceutical ingredient in oral formulations such as capsules and oral drops. Its use requires appropriate clinical supervision and monitoring of calcium and phosphate levels.
Swapnroop Drugs and Pharmaceuticals provides product information for Alfacalcidol API for pharmaceutical and commercial enquiries. Grade, specifications, batch quality, documentation and availability should be confirmed against the applicable Certificate of Analysis (COA).
Alfacalcidol is described in pharmaceutical reference information as a white or almost white crystalline material. It is sensitive to light and practically insoluble in water.
Alfacalcidol is a vitamin D analogue that undergoes 25-hydroxylation in the liver to form 1,25-dihydroxyvitamin D3, the active hormonal form of vitamin D.
The active metabolite acts through vitamin D receptors and helps regulate calcium and phosphate homeostasis. It promotes intestinal absorption of calcium and phosphate and contributes to normal bone mineral metabolism.
Alfacalcidol is used in pharmaceutical formulations for conditions involving vitamin D metabolism and calcium regulation.
Its pharmaceutical application areas include:
Alfacalcidol is covered by pharmacopoeial quality references, including the European Pharmacopoeia. The relevant monograph and approved supplier specification should be used to establish identification, assay, related substances, water content and other quality requirements.
For material supplied as USP grade, confirm compliance with the current official USP-NF monograph and the batch-specific Certificate of Analysis. Do not substitute European Pharmacopoeia or British Pharmacopoeia acceptance limits for USP requirements.
Swapnroop Drugs and Pharmaceuticals supports pharmaceutical product enquiries with chemical identification details, technical information and quality documentation.
For Alfacalcidol API enquiries, customers can request applicable grade information, batch COA, analytical specifications, packaging details and commercial information.
Contact the SDP team to confirm current product specifications and availability.
Alfacalcidol is a synthetic vitamin D3 analogue also known as 1α-hydroxyvitamin D3.
The CAS number is 41294-56-8.
The molecular formula is C27H44O2.
The molecular weight is approximately 400.65 g/mol.
It is described as a white or almost white crystalline material.
A pharmaceutical product monograph reports a melting range of 136°C–144°C.
Alfacalcidol is practically insoluble in water and very soluble in methanol, ethanol and chloroform.
It is used in formulations for selected conditions involving vitamin D metabolism, calcium regulation and bone metabolism.
For product specifications, technical documentation, batch COA, availability and commercial enquiries regarding Alfacalcidol API, contact Swapnroop Drugs and Pharmaceuticals.
Website: https://www.sdp.org.in/
| Parameter | Specification |
|---|---|
| Appearance | White or almost white crystals |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 98.5–100.5% |
| Loss on Drying | NMT 0.5% |
| Residue on Ignition | NMT 0.05% |
| Heavy Metals | NMT 10 ppm |
| pH (1% Solution) | 2.0 - 4.0 |
| Melting Point | 136°C–144°C |
| Solubility | Practically insoluble in water; very soluble in methanol, ethanol and chloroform |